At the heart of Ad Scientiam’s project is a conviction: continuously measuring and following the evolution of severe and disabling diseases in real life is the key to better care for patients.
Ad Scientiam is taking this scientific and technological bet, so that today each patient can be an actor in their own health and to accelerate the development of new treatments.
We are committed to ensuring that the medicine of tomorrow is more predictive, preventive and individualized.
We make it the foundation of our activity.
Hitherto undetectable, these evolutions are now visible through the design and clinical validation of digital biomarkers. These are derived from data continuously collected via a digital tool, such as the patient's smartphone for example, and transformed by proprietary algorithms.
Their use allows Ad Scientiam to provide innovative, easy-to-use and intuitive solutions for:
Help them to measure in real life the evolution of their health and facilitate clinical decision-making by healthcare professionals.
Accelerate drug development
Accelerate drug development by deploying new criteria for evaluating their efficacy.
Reduce the societal and economic impact
Reduce the societal and economic impact of diseases through new care pathways for patients.
We want to be useful, starting today, to the greatest number of patients. For them, as a pioneer in digital biomarkers, we have set ourselves ambitious objectives, which we are pursuing relentlessly.
Our obsession is to get results quickly, because our scientific and technological advances only make sense if they are shared widely and rapidly.
We do this without compromising on the security and confidentiality of the health data entrusted to us.
Security & confidentiality
Every day, we combine our expertise with our agility to create an inclusive environment, fostering innovation and thus passionately support our mission to serve patients.
Ad Scientiam brings together a team of more than 40 people, passionate about digital healthcare innovation.
Mobile development, UX / UI, Clinical Research, Data Science, Product, we put the diversity of our skills and our creativity at the service of the patient.
Do you want to know more about our professions? Find testimonials from :
- Bénédicte (International clinical project manager)
- Angéline (Data Scientist)
- Théo (Product Owner)
Matthieu graduated from HEC Paris. For nearly ten years, he advised large international groups on the implementation of reorganization, digital transformation and startup acceleration projects. He joined Ad Scientiam at the end of 2016 to accelerate and structure the development of the company in the United States. Returning to France in the summer of 2020, he gradually took over the executive functions of the company, first as Chief Executive Officer, and, since October 2021, as President of Ad Scientiam.
Saad is a physician and holds an MBA from ESCP Europe. After clinical experience in radiology (Charles-Foix, Pierre and Marie Curie University), he spent 25 years in multinational pharmaceutical companies where he took on marketing, medical and commercial responsibilities. In his last position at Recordati France, he set up the addiction business unit and successfully launched several treatments in hypertension, migraine, allergy, urology, OTC and generics. He joined Ad Scientiam in 2016 where he took charge of scientific and medical activities.
Térence has a background in cognitive psychology, neuropsychology, ergonomics and UX design. Co-founder of Ad Scientiam, he ensures a user centered approach by integrating patient and clinician insights through the design process of Ad Scientiam solutions.
François de Berry
Expert in computer sciences, graduated at EPITECH, François quickly specialized in mobile technologies. Since 2013, he is in charge of the development and evolution of innovative mobile solutions developed by Ad Scientiam.
Nicolas Von Bandel
Nicolas est docteur en Électronique, Physique et Traitement du Signal de l’université de Montpellier II et Ingénieur Civil de l’École des Mines de Paris. Après une thèse industrielle sur la réalisation de composants optiques pour systèmes métrologiques embarqués dans l’espace, il a travaillé comme Technical Lead système dans l’imagerie médicale appliquée à l’endoscopie. Il rejoint Ad Scientiam début 2021 et prend la tête du pôle Product Management.
Séverine holds a PhD in Physiology and Physiopathology, graduated from the University of Paris 6. She worked for more than 15 years in clinical research in private and public laboratories on phase III and IV studies and joined Ad Scientiam at the end of 2016. She is in charge of the clinical research department and the conduct of pre- and post-marketing clinical evaluation for mobile applications developed by Ad Scientiam in compliance with regulations.
Loïc holds a PhD in Neuroscience, a graduate of Pierre and Marie Curie University, Paris VI. Before Ad Scientiam, Loïc was a post-doctoral researcher in an INSERM laboratory and he brings his experience and rigor to understanding scientific and clinical needs. Loïc heads the data division at Ad Scientiam (Data Science, Data Management, Biostatistics). He is responsible for defining and implementing the company's Data strategy, and supporting the development, validation and implementation of digital biomarkers obtained through our software medical devices.
Clarissa has a PhD in Pharmacy, with a double degree in Pharmaceutical Management and Biotechnology from ESCP Business school. Passionate about new technologies and their applications in the health sector, she has a first experience in a startup specializing in blockchain. She joined Ad Scientiam in 2020 as Head of Medical Innovation. This pole is in charge of defining the medical need during the framing phases, in collaboration with patients, patient associations and healthcare professionals in order to conceptualize the new digital solutions of Ad Scientiam.
Jean-François Lujan Santos
Graduated with a Master degree in Engineering in Applied Mechanical Methods. Jean-François has worked for 19 years in the Medical Devices sector from Class I to III as a Director of Regulatory Affairs/Quality and as a Head of Research and Development in Implantable Medical Devices. Jean-François joined Ad Scientiam in 2020 where he is in charge of CE-marking of software medical devices and the ISO 13485 certification of Quality Management System.
With a Master's degree from ESGRH in Human Resources Management and specialized in labor relations, Nina joined Ad Scientiam as Human Resources Manager in 2019. She is in charge of human resources development and the well-being of collaborators.